Go to:
Logótipo
Você está em: Start > Publications > View > Evaluation of the Cytotoxic and Antiviral Effects of Small Molecules Selected by In Silico Studies as Inhibitors of SARS-CoV-2 Cell Entry
Map of Premises
Principal
Publication

Evaluation of the Cytotoxic and Antiviral Effects of Small Molecules Selected by In Silico Studies as Inhibitors of SARS-CoV-2 Cell Entry

Title
Evaluation of the Cytotoxic and Antiviral Effects of Small Molecules Selected by In Silico Studies as Inhibitors of SARS-CoV-2 Cell Entry
Type
Article in International Scientific Journal
Year
2023
Authors
Carvalhal, F
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Magalhaes, AC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rebelo, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Resende, DISP
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Duraes, F
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Maia, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Xavier, CPR
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pereira, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Emilia Sousa
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Marta Correia da Silva
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Helena Vasconcelos, MH
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Title: MoleculesImported from Authenticus Search for Journal Publications
Vol. 28 No. 3
Final page: 7204
ISSN: 1420-3049
Publisher: MDPI
Other information
Authenticus ID: P-00Z-A3W
Abstract (EN): The spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relies on host cell surface glycans to facilitate interaction with the angiotensin-converting enzyme 2 (ACE-2) receptor. This interaction between ACE2 and the spike protein is a gateway for the virus to enter host cells and may be targeted by antiviral drugs to inhibit viral infection. Therefore, targeting the interaction between these two proteins is an interesting strategy to prevent SARS-CoV-2 infection. A library of glycan mimetics and derivatives was selected for a virtual screening performed against both ACE2 and spike proteins. Subsequently, in vitro assays were performed on eleven of the most promising in silico compounds to evaluate: (i) their efficacy in inhibiting cell infection by SARS-CoV-2 (using the Vero CCL-81 cell line as a model), (ii) their impact on ACE2 expression (in the Vero CCL-81 and MDA-MB-231 cell lines), and (iii) their cytotoxicity in a human lung cell line (A549). We identified five synthetic compounds with the potential to block SARS-CoV-2 infection, three of them without relevant toxicity in human lung cells. Xanthene 1 stood out as the most promising anti-SARS-CoV-2 agent, inhibiting viral infection and viral replication in Vero CCL-81 cells, without causing cytotoxicity to human lung cells.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 19
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Wound-Healing Peptides for Treatment of Chronic Diabetic Foot Ulcers and Other Infected Skin Injuries (2017)
Another Publication in an International Scientific Journal
Gomes, A; Catia Teixeira; Ferraz, R; Prudencio, C; Paula Gomes
Wine Flavonoids in Health and Disease Prevention (2017)
Another Publication in an International Scientific Journal
Iva Fernandes; Pérez Gregorio, R; Susana Soares; Nuno Mateus; Victor de Freitas; Santos Buelga, C; Feliciano, AS
Valorization of Winemaking By-Products as a Novel Source of Antibacterial Properties: New Strategies to Fight Antibiotic Resistance (2021)
Another Publication in an International Scientific Journal
Silva, A; Silva, V; Igrejas, G; Gaivao, I; Aires, A; Klibi, N; Dapkevicius, MDE; Patricia Valentao; Falco, V; Poeta, P
Uncovering the Metabolic Footprint of New Psychoactive Substances by Metabolomics: A Systematic Review (2025)
Another Publication in an International Scientific Journal
Almeida, AS; de Pinho, PG; Fernando Remiao; Carla Fernandes
Trending Topics on Coumarin and Its Derivatives in 2020 (2021)
Another Publication in an International Scientific Journal
Carneiro, A; Matos, MJ; Uriarte, E; Santana, L

See all (336)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-17 at 23:03:19 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book